Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Turku PET Centre, Turku, Finland
Penn State Milton S Hershey Medical Ctr, Hershey, Pennsylvania, United States
Assiut university hospital, Assiut, Egypt
Chonnam National University Hospital, Gwangju, Korea, Republic of
Assiut university hospitals, Assiut, Assiut governorate, Egypt
University of Missouri Hospitals, Columbia, Missouri, United States
Cukurova University Faculty of Medicine Research Hospital, Adana, Turkey
Sir Ganga Ram Hospital, New Delhi, India
Chung-Ang University Hospital, Seoul, Korea, Republic of
Departement d'anesthesie Hopital Armand Trousseau, Paris, France
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.